Possible role of Pax-6 in promoting breast cancer cell proliferation and tumorigenesis |
Zong, Xiangyun
(Department of Breast Surgery, Zhejiang Provincial Cancer Hospital)
Yang, Hongjian (Department of Breast Surgery, Zhejiang Provincial Cancer Hospital) Yu, Yang (Department of Breast Surgery, Zhejiang Provincial Cancer Hospital) Zou, Dehong (Department of Breast Surgery, Zhejiang Provincial Cancer Hospital) Ling, Zhiqiang (Department of Breast Surgery, Zhejiang Provincial Cancer Hospital) He, Xiangming (Department of Breast Surgery, Zhejiang Provincial Cancer Hospital) Meng, Xuli (Department of Breast Surgery, Zhejiang Provincial Cancer Hospital) |
1 | Hellwinkel, O. J., Kedia, M., Isbarn, H., Budaus, L. and Friedrich, M. G. (2008) Methylation of the TPEF- and PAX6-promoters is increased in early bladder cancer and in normal mucosa adjacent to pTa tumours. BJU Int. 101, 753-757. DOI ScienceOn |
2 | Shyr, C. R., Tsai, M. Y., Yeh, S., Kang, H. Y., Chang, Y. C., Wong, P. L., Huang, C. C., Huang, K. E. and Chang, C. (2010) Tumor suppressor PAX6 functions as androgen receptor co-repressor to inhibit prostate cancer growth. Prostate 70, 190-199. |
3 | Vouyovitch, C. M., Vidal, L., Borges, S., Raccurt, M., Arnould, C., Chiesa, J., Lobie, P. E., Lachuer, J. and Mertani, H. C. (2008) Proteomic analysis of autocrine/paracrine effects of human growth hormone in human mammary carcinoma cells. Adv. Exp. Med. Biol. 617, 493-500. DOI ScienceOn |
4 | Muratovska, A., Zhou, C., He, S., Goodyer, P. and Eccles, M. R. (2003) Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene 22, 7989-7997. DOI ScienceOn |
5 | Nizamutdinova, I. T., Lee, G. W., Son, K. H., Jeon, S. J., Kang, S. S., Kim, Y. S., Lee, J. H., Seo, H. G., Chang, K. C. and Kim, H. J. (2008) Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells. Int. J. Oncol. 33, 485-491. |
6 | Anandappa, S. Y., Sibson, R., Platt-Higgins, A., Winstanley, J. H., Rudland, P. S. and Barraclough, R. (2000) Variant estrogen receptor alpha mRNAs in human breast cancer specimens. Int. J. Cancer 88, 209-216. DOI ScienceOn |
7 | Kashiwagi, Y., Kato, N., Sassa, T., Nishitsuka, K., Yamamoto, T., Takamura, H. and Yamashita, H. (2010) Cotylenin A inhibits cell proliferation and induces apoptosis and PAX6 mRNA transcripts in retinoblastoma cell lines. Mol. Vis. 16, 970-982. |
8 | Niemeier, L. A., Dabbs, D. J., Beriwal. S., Striebel, J. M. and Bhargava, R. (2010) Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation. Mod. Pathol. 23, 205-212. DOI ScienceOn |
9 | Maekawa, M., Takashima, N., Arai, Y., Nomura, T., Inokuchi, K., Yuasa, S. and Osumi, N. (2005) Pax6 is required for production and maintenance of progenitor cells in postnatal hippocampal neurogenesis. Genes Cells 10, 1001-1014. DOI ScienceOn |
10 | Osumi, N., Shinohara, H., Numayama-Tsuruta, K. and Maekawa, M. (2008) Concise review: Pax6 transcription factor contributes to both embryonic and adult neurogenesis as a multifunctional regulator. Stem. Cells 26, 1663-1672. DOI ScienceOn |
11 | Sakurai, K. and Osumi, N. (2008) The neurogenesis- controlling factor, Pax6, inhibits proliferation and promotes maturation in murine astrocytes. J. Neurosci. 28, 4604-4612. DOI ScienceOn |
12 | Warren, N., Caric, D., Pratt, T., Clausen, J. A., Asavaritikrai, P., Mason, J. O., Hill, R. E. and Price, D. J. (1999) The transcription factor, Pax6, is required for cell proliferation and differentiation in the developing cerebral cortex. Cereb. Cortex 9, 627-635. DOI ScienceOn |
13 | Simpson, T. I. and Price, D. J. (2002) Pax6; a pleiotropic player in development. Bioessays 24, 1041-1051. DOI ScienceOn |
14 | Zhang, J., Lu, J. P., Suter, D. M., Krause, K. H., Fini, M. E., Chen, B. and Lu, Q. (2010) Isoform- and dose-sensitive feedback interactions between paired box 6 gene and delta- catenin in cell differentiation and death. Exp. Cell. Res. 316, 1070-1081. DOI ScienceOn |
15 | Shimizu, N., Watanabe, H., Kubota, J., Wu, J., Saito, R., Yokoi, T., Era, T., Iwatsubo, T., Watanabe, T., Nishina, S., Azuma, N., Katada, T. and Nishina, H. (2009) Pax6-5a promotes neuronal differentiation of murine embryonic stem cells. Biol. Pharm. Bull. 32, 999-1003. DOI ScienceOn |
16 | Mascarenhas, J. B., Young, K. P., Littlejohn, E. L., Yoo, B. K., Salgia, R. and Lang, D. (2009) PAX6 is expressed in pancreatic cancer and actively participates in cancer progression through activation of the MET tyrosine kinase receptor gene. J. Biol. Chem. 284, 27524-27532. DOI ScienceOn |
17 | Walther, C., Guenet, J. L., Simon, D., Deutsch, U., Jostes, B., Goulding, M. D., Plachov, D., Balling, R. and Gruss, P. (1991) Pax: a murine multigene family of paired box-containing genes. Genomics 11, 424-434. DOI |
18 | Walther, C. and Gruss, P. (1991) Pax-6, a murine paired box gene, is expressed in the developing CNS. Development 113, 1435-1449. |
19 | Hill, R. E., Favor, J., Hogan, B. L., Ton, C. C., Saunders, G. F., Hanson, I. M., Prosser, J., Jordan, T., Hastie, N. D. and van Heyningen, V. (1992) Mouse small eye results from mutations in a paired-like homeobox-containing gene. Nature 355, 750. DOI ScienceOn |
20 | Kioussi, C., O'Connell, S., St-Onge, L., Treier, M., Gleiberman, A. S., Gruss, P. and Rosenfeld, M. G. (1999) Pax6 is essential for establishing ventral-dorsal cell boundaries in pituitary gland development. Proc. Natl. Acad. Sci. U.S.A. 96, 14378-14382. DOI |
21 | Dohrmann, C., Gruss, P. and Lemaire, L. (2000) Pax genes and the differentiation of hormone-producing endocrine cells in the pancreas. Mech. Dev. 92, 47-54. DOI ScienceOn |
22 | Phipps, S. M., Love, W. K., White, T., Andrews, L. G. and Tollefsbol, T. O. (2009) Retinoid-induced histone deacetylation inhibits telomerase activity in estrogen receptornegative breast cancer cells. Anticancer Res. 29, 4959-4964. |
23 | Zhang, D., LaFortune, T. A., Krishnamurthy, S., Esteva, F. J., Cristofanilli, M., Liu, P., Lucci, A., Singh, B., Hung, M. C., Hortobagyi, G. N. and Ueno, N. T (2009). Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer. Clin Cancer Res.15, 6639-6648. DOI ScienceOn |